tiprankstipranks
Trending News
More News >
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market

Bicycle Therapeutics (BCYC) Financial Statements

Compare
404 Followers

Bicycle Therapeutics Financial Overview

Bicycle Therapeutics's market cap is currently $458.81M. The company's EPS TTM is $-0.85; its P/E ratio is -1.78; Bicycle Therapeutics is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 35.27M$ 26.98M$ 14.46M$ 11.70M$ 10.39M
Gross Profit$ -137.69M$ -129.52M$ 14.46M$ 11.70M$ -22.76M
Operating Income$ -209.87M$ -189.95M$ -116.65M$ -65.62M$ -51.96M
EBITDA$ -164.89M$ -183.40M$ -107.21M$ -64.09M$ -50.68M
Net Income$ -169.03M$ -180.66M$ -112.72M$ -66.82M$ -51.01M
Balance Sheet
Cash & Short-Term Investments$ 879.52M$ 526.42M$ 339.15M$ 438.68M$ 135.99M
Total Assets$ 956.87M$ 595.34M$ 410.61M$ 479.79M$ 161.15M
Total Debt$ 9.49M$ 44.96M$ 44.33M$ 44.34M$ 15.78M
Net Debt$ -870.03M$ -481.47M$ -294.83M$ -394.34M$ -120.22M
Total Liabilities$ 163.81M$ 224.41M$ 139.83M$ 133.54M$ 65.69M
Stockholders' Equity$ 793.06M$ 370.93M$ 270.78M$ 346.25M$ 95.46M
Cash Flow
Free Cash Flow$ -165.96M$ -63.56M$ -105.10M$ -16.82M$ -18.99M
Operating Cash Flow$ -164.72M$ -60.63M$ -86.11M$ -14.79M$ -17.79M
Investing Cash Flow$ -1.24M$ -2.93M$ -18.99M$ -2.03M$ -1.20M
Financing Cash Flow$ 519.75M$ 250.03M$ 6.69M$ 320.73M$ 62.84M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Bicycle Therapeutics Debt to Assets

Bicycle Therapeutics Cash Flow

Bicycle Therapeutics Forecast EPS vs Actual EPS